Inovio Pharmaceuticals, Inc. (INO): Price and Financial Metrics
Inovio Pharmaceuticals, Inc. (INO)
Today's Latest Price: $16.52 USD
Updated Sep 25 12:59pm
Add INO to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
INO Stock Summary
- With a price/sales ratio of 939.43, Inovio Pharmaceuticals Inc has a higher such ratio than 99.37% of stocks in our set.
- As for revenue growth, note that INO's revenue has grown -63.3% over the past 12 months; that beats the revenue growth of just 2.65% of US companies in our set.
- The volatility of Inovio Pharmaceuticals Inc's share price is greater than that of 95% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Inovio Pharmaceuticals Inc, a group of peers worth examining would be MRSN, ARNA, CBMG, GERN, and CRMD.
- Visit INO's SEC page to see the company's official filings. To visit the company's web site, go to www.inovio.com.
INO Stock Price Chart Technical Analysis Charts
INO Price/Volume Stats
| Current price | $16.52 | 52-week high | $33.79 |
| Prev. close | $15.37 | 52-week low | $1.91 |
| Day low | $15.85 | Volume | 9,524,679 |
| Day high | $16.96 | Avg. volume | 30,894,619 |
| 50-day MA | $16.39 | Dividend yield | N/A |
| 200-day MA | $11.41 | Market Cap | 2.77B |
Inovio Pharmaceuticals, Inc. (INO) Company Bio
Inovio Pharmaceuticals is a clinical stage biopharmaceutical company, developing active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. The company was founded in 1979 and is based in Plymouth Meeting, Pennsylvania.
Loading social stream, please wait...